BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25157160)

  • 1. Ghrelin promotes hepatic lipogenesis by activation of mTOR-PPARγ signaling pathway.
    Li Z; Xu G; Qin Y; Zhang C; Tang H; Yin Y; Xiang X; Li Y; Zhao J; Mulholland M; Zhang W
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13163-8. PubMed ID: 25157160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
    Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ.
    Chen J; Wang W; Qi Y; Kaczorowski D; McCaughan GW; Gamble JR; Don AS; Gao X; Vadas MA; Xia P
    Biochim Biophys Acta; 2016 Feb; 1861(2):138-147. PubMed ID: 26615875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male Mice.
    Kineman RD; Majumdar N; Subbaiah PV; Cordoba-Chacon J
    Endocrinology; 2016 May; 157(5):1728-35. PubMed ID: 26950202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ghrelin ameliorates nonalcoholic steatohepatitis induced by chronic low-grade inflammation via blockade of Kupffer cell M1 polarization.
    Yin Y; Wang Q; Qi M; Zhang C; Li Z; Zhang W
    J Cell Physiol; 2021 Jul; 236(7):5121-5133. PubMed ID: 33345314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of mitogen-activated protein kinase phosphatase-1 protects from hepatic steatosis by repression of cell death-inducing DNA fragmentation factor A (DFFA)-like effector C (CIDEC)/fat-specific protein 27.
    Flach RJ; Qin H; Zhang L; Bennett AM
    J Biol Chem; 2011 Jun; 286(25):22195-202. PubMed ID: 21521693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
    Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
    Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
    Liu J; Tang T; Wang GD; Liu B
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
    [No Abstract]   [Full Text] [Related]  

  • 9. Acylated ghrelin induces but deacylated ghrelin prevents hepatic steatosis and insulin resistance in lean rats: Effects on DAG/ PKC/JNK pathway.
    Dallak MA
    Biomed Pharmacother; 2018 Sep; 105():299-311. PubMed ID: 29860222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR Signaling in X/A-Like Cells Contributes to Lipid Homeostasis in Mice.
    Li Z; Yu R; Yin W; Qin Y; Ma L; Mulholland M; Zhang W
    Hepatology; 2019 Feb; 69(2):860-875. PubMed ID: 30141265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation is independent of steatosis in a murine model of steatohepatitis.
    Wang W; Xu MJ; Cai Y; Zhou Z; Cao H; Mukhopadhyay P; Pacher P; Zheng S; Gonzalez FJ; Gao B
    Hepatology; 2017 Jul; 66(1):108-123. PubMed ID: 28220523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice.
    Liu TY; Xiong XQ; Ren XS; Zhao MX; Shi CX; Wang JJ; Zhou YB; Zhang F; Han Y; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
    Diabetes; 2016 Nov; 65(11):3262-3275. PubMed ID: 27504012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanism of Betaine on Hepatic Lipid Metabolism: Inhibition of Forkhead Box O1 (FoxO1) Binding to Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).
    Kim DH; Lee B; Kim MJ; Park MH; An HJ; Lee EK; Chung KW; Park JW; Yu BP; Choi JS; Chung HY
    J Agric Food Chem; 2016 Sep; 64(36):6819-25. PubMed ID: 27546313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.
    Wolf Greenstein A; Majumdar N; Yang P; Subbaiah PV; Kineman RD; Cordoba-Chacon J
    J Endocrinol; 2017 Jan; 232(1):107-121. PubMed ID: 27799461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin Stimulates Hepatocyte Proliferation via Regulating Cell Cycle Through GSK3β/Β-Catenin Signaling Pathway.
    Wang Q; Zheng M; Yin Y; Zhang W
    Cell Physiol Biochem; 2018; 50(5):1698-1710. PubMed ID: 30384380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease.
    Chen H; Shen F; Sherban A; Nocon A; Li Y; Wang H; Xu MJ; Rui X; Han J; Jiang B; Lee D; Li N; Keyhani-Nejad F; Fan JG; Liu F; Kamat A; Musi N; Guarente L; Pacher P; Gao B; Zang M
    Hepatology; 2018 Aug; 68(2):496-514. PubMed ID: 29457836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric mammalian target of rapamycin signaling regulates ghrelin production and food intake.
    Xu G; Li Y; An W; Li S; Guan Y; Wang N; Tang C; Wang X; Zhu Y; Li X; Mulholland MW; Zhang W
    Endocrinology; 2009 Aug; 150(8):3637-44. PubMed ID: 19406939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.
    Zhang C; Luo X; Chen J; Zhou B; Yang M; Liu R; Liu D; Gu HF; Zhu Z; Zheng H; Li L; Yang G
    Diabetes; 2019 Oct; 68(10):1902-1914. PubMed ID: 31292134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.